Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In West, sinusoidal obstruction syndrome (SOS) is often complicated with hemopoietic stem cell transplantation. By comparison, in China, SOS is frequently caused by Tusanqi-containing pyrrolizidine alkaloids. A systematic review aimed to evaluate the clinical profiles, diagnostic workup, treatment, and outcomes of Tusanqi-related SOS in China. All relevant articles were searched via PubMed, China Knowledge Resource Integrated, VIP, and Wanfang databases. Case reports were defined, as the data were available in every individual patient. Otherwise, case series were defined. Overall, 106 articles were eligible. Fifty-six case reports included 84 individual patients with SOS secondary to Tusanqi alone. All of them presented with ascites, but only 1 patient presented with upper gastrointestinal bleeding. The 1-, 3-, and 6-month cumulative survival rate was 98%, 87%, and 76%, respectively. Increased bilirubin and aspartate transaminase levels were significantly associated with poor outcome. Thirty-one case series included 402 patients with SOS secondary to Tusanqi alone. Ascites was observed in 94% of patients, but upper gastrointestinal bleeding was observed in 40% of patients. Recovery, stabilization, progression, and death were observed in 41%, 30%, 14%, and 16% of patients, respectively. Nineteen case series included 281 patients with SOS secondary to mixed etiologies. The pooled proportion of Tusanqi-related SOS was 66% (95% confidence interval: 56%-75%). Tusanqi is a major cause of SOS in China. Ascites is the most common clinical presentation of Tusanqi-related SOS. Despite a relatively good short-term outcome, further studies should be necessary to explore the long-term outcome and refine the treatment strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular disorders of the liver # †
DeLeve, L. D., Valla, D.-C., & Garcia-Tsao, G. (2009) · Hepatology · doi:10.1002/hep.22772 · Cited by 978
Find Duplicates among the PubMed, EMBASE, and Cochrane Library Databases in Systematic Review
Qi, X., Yang, M., Ren, W., Jia, J., Wang, J., Han, G., & Fan, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071838 · Cited by 98
Self-citationIL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production
Mitola, S., Strasly, M., Prato, M., Ghia, P., & Bussolino, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3725 · Cited by 58
Cited by
Yang, X.-Q., Ye, J., Li, X., Li, Q., & Song, Y.-H. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i28.3753 · Cited by 82
Wang, R., Qi, X., Yoshida, E. M., Méndez-Sánchez, N., Teschke, R., Sun, M., Liu, X., Su, C., Deng, J., Deng, H., et al. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1427581 · Cited by 50
Self-citationChen, Y., Xiong, F., Wang, W., Jiang, K., Ye, X., Deng, G., Wang, C., Yang, L., Xiong, A., & Wang, Z. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.01.021 · Cited by 23
Wang, X., Zhang, W., Zhang, M., Zhang, F., Xiao, J., Yin, Q., Han, H., Li, T., Lin, G., & Zhuge, Y. (2022) · Hepatology International · doi:10.1007/s12072-021-10293-5 · Cited by 20
Self-citation
Metadata
- Authors
- Wang, X., Qi, X., & Guo, X.
- Venue
- Medicine
- Published
- 2015-06
- Volume
- 94
- Issue
- 23
- Pages
- e942
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2316688214
- Cited by
- 52
- References
- 3
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures. https://app.cochat.ai/papers/10.1097/md.0000000000000942
- The paper
- Wang, X., Qi, X., & Guo, X. (2015). Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures. Medicine. https://doi.org/10.1097/md.0000000000000942
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.